Vera Therapeutics Ownership 2024 | Who Owns Vera Therapeutics Now?
Institutional Ownership
13.18%
Insider Ownership
7.85%
Retail Ownership
78.98%
Institutional Holders
48.00
Vera Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 8.45% | 2.08% | 4,309,590 | -955,410 | -18.15% | 155,920,966 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 7.10% | 0.02% | 3,620,135 | 1,227,106 | 51.28% | 130,977,000 | Jun 30, 2024 |
| BLACKROCK INC. | 6.55% | 0.00% | 3,337,672 | 18,708 | 0.56% | 120,756,973 | Jun 30, 2024 |
| FMR LLC | 5.50% | 0.01% | 2,801,938 | -321,330 | -10.29% | 101,374,117 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 5.48% | 5.25% | 2,793,987 | - | - | 101,086,450 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.95% | 0.00% | 2,524,176 | 375,462 | 17.47% | 91,324,688 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 4.86% | 6.11% | 2,475,000 | -690,000 | -21.80% | 89,545,500 | Jun 30, 2024 |
| STATE STREET CORP | 4.23% | 0.00% | 2,155,553 | -195,174 | -8.30% | 77,987,908,000 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 4.01% | 5.06% | 2,043,214 | 219,433 | 12.03% | 73,923,483 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 3.52% | 0.27% | 1,796,077 | 588,697 | 48.76% | 64,982,066 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 3.03% | 4.31% | 1,543,669 | 16,882 | 1.11% | 55,849,944 | Jun 30, 2024 |
| SAMLYN CAPITAL, LLC | 2.42% | 0.74% | 1,231,911 | 586,410 | 90.85% | 44,570,540 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.20% | 0.07% | 1,119,000 | 281,805 | 33.66% | 40,485,420 | Jun 30, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 1.97% | 3.19% | 1,005,723 | 569,590 | 130.60% | 36,387,058 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.93% | 0.00% | 984,442 | 23,133 | 2.41% | 35,624,594 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 1.86% | 2.79% | 950,000 | 375,000 | 65.22% | 34,371,000 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 1.86% | 0.33% | 948,917 | 1,820 | 0.19% | 34,331,817 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.80% | 0.84% | 915,974 | 409,955 | 81.02% | 33,139,939 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.54% | 0.00% | 784,568 | 224,778 | 40.15% | 28,385,671 | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | 1.52% | 0.91% | 772,675 | 178,584 | 30.06% | 27,955,382 | Jun 30, 2024 |
Vera Therapeutics's largest institutional shareholder is AVORO CAPITAL ADVISORS LLC, holding 8.45% of the company's total share outstanding, currently valued at $155.92M. The top 10 institutional shareholders own together 54.65% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALTIUM CAPITAL MANAGEMENT LP | 1.40% | 10.54% | 714,000 | 4,000 | 0.56% | 25,832,520 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 4.86% | 6.11% | 2,475,000 | -690,000 | -21.80% | 89,545,500 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 5.48% | 5.25% | 2,793,987 | - | - | 101,086,450 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 4.01% | 5.06% | 2,043,214 | 219,433 | 12.03% | 73,923,483 | Jun 30, 2024 |
| PORTMAN LTD | 0.06% | 4.48% | 32,795 | 32,795 | 100.00% | 1,186,523 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 3.03% | 4.31% | 1,543,669 | 16,882 | 1.11% | 55,849,944 | Jun 30, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 1.97% | 3.19% | 1,005,723 | 569,590 | 130.60% | 36,387,058 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 1.86% | 2.79% | 950,000 | 375,000 | 65.22% | 34,371,000 | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.45% | 2.51% | 230,000 | 230,000 | 100.00% | 8,321,400 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 8.45% | 2.08% | 4,309,590 | -955,410 | -18.15% | 155,920,966 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.98% | 1.72% | 500,000 | 140,000 | 38.89% | 18,090,000 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.74% | 1.56% | 375,000 | -95,000 | -20.21% | 13,567,500 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.42% | 1.25% | 212,944 | 94,684 | 80.06% | 7,704,314 | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | 1.52% | 0.91% | 772,675 | 178,584 | 30.06% | 27,955,382 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.80% | 0.84% | 915,974 | 409,955 | 81.02% | 33,139,939 | Jun 30, 2024 |
| DECHENG CAPITAL LLC | 0.14% | 0.77% | 69,767 | 69,767 | 100.00% | 2,524,170 | Jun 30, 2024 |
| SAMLYN CAPITAL, LLC | 2.42% | 0.74% | 1,231,911 | 586,410 | 90.85% | 44,570,540 | Jun 30, 2024 |
| WILLIAM MARSH RICE UNIVERSITY | 0.03% | 0.66% | 16,397 | 16,397 | 100.00% | 593,243 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 1.33% | 0.49% | 675,872 | - | - | 24,453,049 | Jun 30, 2024 |
| ALPHABET INC. | 0.47% | 0.44% | 241,264 | - | - | 8,728,932 | Jun 30, 2024 |
The largest Vera Therapeutics shareholder by % of total assets is ALTIUM CAPITAL MANAGEMENT LP. The company owns 714.00K shares of Vera Therapeutics (VERA), representing 10.54% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | 7.10% | 0.02% | 3,620,135 | 1,227,106 | 51.28% | 130,977,000 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 3.52% | 0.27% | 1,796,077 | 588,697 | 48.76% | 64,982,066 | Jun 30, 2024 |
| SAMLYN CAPITAL, LLC | 2.42% | 0.74% | 1,231,911 | 586,410 | 90.85% | 44,570,540 | Jun 30, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 1.97% | 3.19% | 1,005,723 | 569,590 | 130.60% | 36,387,058 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.80% | 0.84% | 915,974 | 409,955 | 81.02% | 33,139,939 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.76% | 0.01% | 387,380 | 387,380 | 100.00% | 14,015,427 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.95% | 0.00% | 2,524,176 | 375,462 | 17.47% | 91,324,688 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 1.86% | 2.79% | 950,000 | 375,000 | 65.22% | 34,371,000 | Jun 30, 2024 |
| JENNISON ASSOCIATES LLC | 0.87% | 0.01% | 441,162 | 366,223 | 488.69% | 15,961,241 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.57% | 0.02% | 290,000 | 290,000 | 100.00% | 10,492,200,000 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.57% | 0.07% | 288,444 | 288,444 | 100.00% | 10,435,901 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.20% | 0.07% | 1,119,000 | 281,805 | 33.66% | 40,485,420 | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.45% | 2.51% | 230,000 | 230,000 | 100.00% | 8,321,400 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.54% | 0.00% | 784,568 | 224,778 | 40.15% | 28,385,671 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 4.01% | 5.06% | 2,043,214 | 219,433 | 12.03% | 73,923,483 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.58% | 0.06% | 293,760 | 185,760 | 172.00% | 10,627,741 | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | 1.52% | 0.91% | 772,675 | 178,584 | 30.06% | 27,955,382 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.98% | 1.72% | 500,000 | 140,000 | 38.89% | 18,090,000 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.29% | 0.01% | 148,011 | 112,475 | 316.51% | 5,355,038 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.42% | 1.25% | 212,944 | 94,684 | 80.06% | 7,704,314 | Jun 30, 2024 |
As of Jun 30 2024, Vera Therapeutics's largest institutional buyer is PRICE T ROWE ASSOCIATES INC /MD/. The company purchased 1.23M stocks of VERA, valued at $130.98M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 0.60% | 0.00% | 305,438 | -1,231,352 | -80.12% | 11,050,748 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.23% | 0.01% | 119,000 | -1,056,148 | -89.87% | 4,305,420 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 8.45% | 2.08% | 4,309,590 | -955,410 | -18.15% | 155,920,966 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 4.86% | 6.11% | 2,475,000 | -690,000 | -21.80% | 89,545,500 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.22% | 0.03% | 623,649 | -387,901 | -38.35% | 22,563,621 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | - | - | - | -383,500 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | 5.50% | 0.01% | 2,801,938 | -321,330 | -10.29% | 101,374,117 | Jun 30, 2024 |
| INVESCO LTD. | 0.04% | 0.00% | 18,756 | -288,854 | -93.90% | 678,592 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.73% | 0.01% | 370,685 | -230,351 | -38.33% | 13,411,383 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.26% | 0.00% | 133,774 | -201,790 | -60.13% | 4,839,943 | Jun 30, 2024 |
| STATE STREET CORP | 4.23% | 0.00% | 2,155,553 | -195,174 | -8.30% | 77,987,908,000 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.74% | 1.56% | 375,000 | -95,000 | -20.21% | 13,567,500 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.24% | 0.02% | 121,756 | -53,027 | -30.34% | 4,405,132 | Jun 30, 2024 |
| SEVEN EIGHT CAPITAL, LP | 0.02% | 0.03% | 9,243 | -52,725 | -85.08% | 334,412 | Jun 30, 2024 |
| UBS GROUP AG | 0.15% | 0.00% | 74,462 | -51,921 | -41.08% | 2,694,035 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -40,000 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -37,737 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -37,418 | -100.00% | - | Jun 30, 2024 |
| SECTORAL ASSET MANAGEMENT INC | 0.02% | 0.11% | 7,718 | -37,183 | -82.81% | 279,237 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | - | - | - | -27,000 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Vera Therapeutics's biggest institutional seller is MORGAN STANLEY. The company sold -1.23M shares of VERA, valued at $11.05M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMERICAN CENTURY COMPANIES INC | 0.76% | 0.01% | 387,380 | 387,380 | 100.00% | 14,015,427 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.57% | 0.02% | 290,000 | 290,000 | 100.00% | 10,492,200,000 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.57% | 0.07% | 288,444 | 288,444 | 100.00% | 10,435,901 | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.45% | 2.51% | 230,000 | 230,000 | 100.00% | 8,321,400 | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | 0.18% | 0.07% | 93,176 | 93,176 | 100.00% | 3,371,108 | Jun 30, 2024 |
| DECHENG CAPITAL LLC | 0.14% | 0.77% | 69,767 | 69,767 | 100.00% | 2,524,170 | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.12% | 0.22% | 59,129 | 59,129 | 100.00% | 2,139,287 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.10% | 0.00% | 49,112 | 49,112 | 100.00% | 1,776,872 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.08% | 0.01% | 38,330 | 38,330 | 100.00% | 1,386,000 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 0.07% | 0.00% | 37,400 | 37,400 | 100.00% | 1,353,132 | Jun 30, 2024 |
| CINCTIVE CAPITAL MANAGEMENT LP | 0.07% | 0.06% | 34,772 | 34,772 | 100.00% | 1,258,051 | Jun 30, 2024 |
| PORTMAN LTD | 0.06% | 4.48% | 32,795 | 32,795 | 100.00% | 1,186,523 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 25,735 | 25,735 | 100.00% | 924,124 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 20,966 | 20,966 | 100.00% | 758,550 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.04% | 0.02% | 19,524 | 19,524 | 100.00% | 706,378 | Jun 30, 2024 |
| MAGNETAR FINANCIAL LLC | 0.04% | 0.01% | 18,021 | 18,021 | 100.00% | 652,000 | Jun 30, 2024 |
| WILLIAM MARSH RICE UNIVERSITY | 0.03% | 0.66% | 16,397 | 16,397 | 100.00% | 593,243 | Jun 30, 2024 |
| JASPER RIDGE PARTNERS, L.P. | 0.03% | 0.02% | 15,639 | 15,639 | 100.00% | 565,819 | Jun 30, 2024 |
| ADAMS STREET PARTNERS LLC | 0.03% | 0.20% | 13,114 | 13,114 | 100.00% | 474,465 | Jun 30, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | 0.02% | 0.08% | 12,198 | 12,198 | 100.00% | 441,324 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.02% | 0.00% | 12,058 | 12,058 | 100.00% | 436,258,000 | Jun 30, 2024 |
| CHARTWELL INVESTMENT PARTNERS, LLC | 0.02% | 0.01% | 11,725 | 11,725 | 100.00% | 424,000 | Jun 30, 2024 |
| HANDELSBANKEN FONDER AB | 0.02% | 0.00% | 11,600 | 11,600 | 100.00% | 420,000 | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0.02% | 0.00% | 10,120 | 10,120 | 100.00% | 366,142 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.02% | 0.12% | 9,162 | 9,162 | 100.00% | 331,481 | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | 0.01% | 0.04% | 7,551 | 7,551 | 100.00% | 273,195 | Jun 30, 2024 |
| QUARRY LP | 0.01% | 0.07% | 6,500 | 6,500 | 100.00% | 235,170 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.01% | 0.03% | 4,493 | 4,493 | 100.00% | 162,557 | Jun 30, 2024 |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 0.01% | 0.00% | 3,718 | 3,718 | 100.00% | 135,000 | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | 0.01% | 0.00% | 3,100 | 3,100 | 100.00% | 112,158 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.00% | 0.01% | 1,079 | 1,079 | 100.00% | 39,038 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 81 | 81 | 100.00% | 2,931 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 76 | 76 | 100.00% | 2,750 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 42 | 42 | 100.00% | 1,520 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | - | 0.00% | 13 | 13 | 100.00% | 450 | Jun 30, 2024 |
Vera Therapeutics's largest new institutional shareholder by number of shares is AMERICAN CENTURY COMPANIES INC, purchased 387.38K shares, valued at $14.02M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVIDITY PARTNERS MANAGEMENT LP | - | - | - | -383,500 | -100.00% | - | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -40,000 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -37,737 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -37,418 | -100.00% | - | Jun 30, 2024 |
| J. GOLDMAN & CO LP | - | - | - | -27,000 | -100.00% | - | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | - | - | - | -24,298 | -100.00% | - | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | - | - | - | -22,179 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -20,356 | -100.00% | - | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -20,196 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -19,764 | -100.00% | - | Jun 30, 2024 |
| CARNEGIE MELLON UNIVERSITY | - | - | - | -16,060 | -100.00% | - | Jun 30, 2024 |
| NOMURA HOLDINGS INC | - | - | - | -13,905 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -13,422 | -100.00% | - | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -11,575 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -8,704 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -5,756 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -5,601 | -100.00% | - | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | - | - | - | -5,000 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -3,329 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -2,200 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,125 | -100.00% | - | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -1,500 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -455 | -100.00% | - | Jun 30, 2024 |
| COMERICA BANK | - | - | - | -48 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -7 | -100.00% | - | Jun 30, 2024 |
Vera Therapeutics's largest sold out institutional shareholder by shares sold is AVIDITY PARTNERS MANAGEMENT LP, sold -0.38M shares, valued at -, as of undefined.
Vera Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| T. Rowe Price New Horizons Fund, Inc. | 0.21% | 1,030,887 | 1,030,887 | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.06% | 160,000 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.04% | 1,263,435 | 61,063 | 5.08% | Feb 29, 2024 |
| FIDELITY CAPITAL TRUST | 0.04% | 465,718 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 20,452 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.02% | 211,854 | - | - | Jan 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.02% | 41,859 | 41,859 | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 739,878 | 220,696 | 42.51% | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 70,290 | 7,111 | 11.26% | Mar 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.01% | 48,383 | 48,383 | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,985 | 760 | 14.55% | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 27,727 | 8,291 | 42.66% | Feb 29, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.01% | 280,000 | - | - | Feb 29, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.01% | 16,717 | 16,717 | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 1,060 | -1,476 | -58.20% | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,809,476 | -95,362 | -5.01% | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 29,703 | 2,448 | 8.98% | Jan 31, 2024 |
| ETFis Series Trust I | 0.00% | 5,574 | 5,574 | - | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 25,853 | 25,853 | - | Aug 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 75,000 | - | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 25,312 | 25,312 | - | Mar 28, 2024 |
| ALPS ETF Trust | 0.00% | 32,604 | 1,303 | 4.16% | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 98,291 | 7,653 | 8.44% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 414,106 | 81,751 | 24.60% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 4,000 | 688 | 20.77% | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 3,181 | 3,181 | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 16,867 | -3,001 | -15.10% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 163,944 | 56,841 | 53.07% | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 90,426 | - | - | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 17,932 | -4,021 | -18.32% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 70,553 | -147,266 | -67.61% | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 18,590 | 16,626 | 846.54% | Mar 31, 2024 |
| ProFunds | 0.00% | 9,185 | -672 | -6.82% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 23,001 | 6,919 | 43.02% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 8,499 | -699 | -7.60% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 195,877 | 40,221 | 25.84% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 12,909 | -853 | -6.20% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,921 | 228 | 13.47% | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 227,845 | 49,169 | 27.52% | Feb 29, 2024 |
| Global X Funds | 0.00% | 16,192 | - | - | Jan 31, 2024 |
| AdvisorShares Trust | 0.00% | 1,403 | - | - | Mar 28, 2024 |
| T. Rowe Price Exchange-Traded Funds, Inc. | 0.00% | 2,156 | 2,156 | - | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 13,548 | 12,927 | 2081.64% | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 14,325 | 2,825 | 24.57% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 51,914 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 550 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 24,701 | 2,803 | 12.80% | Mar 28, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 1,506 | 1,506 | - | Mar 28, 2024 |
| RBB FUND, INC. | 0.00% | 14,182 | 14,182 | - | Feb 29, 2024 |
| Victory Portfolios II | 0.00% | 6,316 | 6,316 | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 140,010 | 46,764 | 50.15% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 1,747,166 | 189,081 | 12.14% | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 33,581 | - | - | Jan 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 151,139 | 16,724 | 12.44% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 309 | - | - | Dec 31, 2023 |
| Goldman Sachs ETF Trust | 0.00% | 6,933 | -270 | -3.75% | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 25,670 | 8,471 | 49.25% | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 4,480 | 4,480 | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 6,331 | -1,819 | -22.32% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 12,976 | -52 | -0.40% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,300 | 100 | 8.33% | Mar 28, 2024 |
| SPDR SERIES TRUST | 0.00% | 1,456,220 | -67,566 | -4.43% | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 153 | - | - | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 8,878 | 4,507 | 103.11% | Feb 29, 2024 |
| Series Portfolios Trust | 0.00% | 180 | -1,206 | -87.01% | Jan 31, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 5,878 | 5,878 | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 3,658 | -155 | -4.07% | Jan 31, 2024 |
| Pacer Funds Trust | 0.00% | 933 | 933 | - | Jan 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 2,335 | 2,335 | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 44,784 | 16,584 | 58.81% | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 54,248 | -81,641 | -60.08% | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 20 | - | - | Dec 31, 2023 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 3,780 | 760 | 25.17% | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 13,017 | 1,429 | 12.33% | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 28,014 | 15,005 | 115.34% | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 76 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,189 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,831 | -15 | -0.39% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 10,003 | - | - | Jan 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 968 | 968 | - | Mar 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 25,039 | -20,561 | -45.09% | Mar 28, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 6,792 | -22,505 | -76.82% | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 24,992 | 4,545 | 22.23% | Mar 31, 2024 |
| Columbia Funds Series Trust II | 0.00% | 2,110 | 2,110 | - | Feb 29, 2024 |
| FundVantage Trust | 0.00% | 82 | 82 | - | Mar 28, 2024 |
| EMPOWER FUNDS, INC. | 0.00% | 5,609 | 5,609 | - | Mar 31, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 2,420 | 2,420 | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 500 | 500 | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 14,786 | 2,115 | 16.69% | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 424 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 70 | - | - | Jan 31, 2024 |
| Bridge Builder Trust | 0.00% | 12,102 | 2,138 | 21.46% | Mar 31, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 452 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 4,846 | 652 | 15.55% | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,073 | - | - | Dec 31, 2023 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 307 | -10 | -3.15% | Dec 31, 2023 |
| John Hancock Funds II | 0.00% | 13,852 | 12,252 | 765.75% | Feb 29, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 88 | 22 | 33.33% | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 16,939 | 10,239 | 152.82% | Feb 29, 2024 |
| T. Rowe Price Multi-Strategy Total Return Fund, Inc. | 0.00% | 45 | 45 | - | Jan 31, 2024 |
Vera Therapeutics's largest mutual fund holder by % of total assets is "T. Rowe Price New Horizons Fund, Inc.", owning 1.03M shares, compromising 0.21% of its total assets.
Vera Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 48 | -71.76% |
| 31 Mar, 24 | 170 | 75.26% |
| 31 Dec, 23 | 97 | 12.79% |
| 30 Sep, 23 | 86 | 2.38% |
| 30 Jun, 23 | 84 | 15.07% |
| 31 Mar, 23 | 73 | 25.86% |
| 31 Dec, 22 | 58 | 5.45% |
| 30 Sep, 22 | 55 | 10.00% |
| 30 Jun, 22 | 50 | - |
| 31 Mar, 22 | 50 | 35.14% |
| 31 Dec, 21 | 37 | 19.35% |
| 30 Sep, 21 | 31 | 47.62% |
| 30 Jun, 21 | 21 | - |
As of 30 Jun 24, 48 institutions are holding Vera Therapeutics's shares, representing a decrease of -71.76% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 6,715,916 | -86.91% |
| 31 Mar, 24 | 51,310,371 | 24.10% |
| 31 Dec, 23 | 41,345,655 | 5.32% |
| 30 Sep, 23 | 39,258,889 | 2.97% |
| 30 Jun, 23 | 38,127,621 | 2.07% |
| 31 Mar, 23 | 37,354,444 | 75.10% |
| 31 Dec, 22 | 21,332,619 | -0.96% |
| 30 Sep, 22 | 21,539,850 | 5.61% |
| 30 Jun, 22 | 20,394,973 | 3.66% |
| 31 Mar, 22 | 19,674,561 | 39.98% |
| 31 Dec, 21 | 14,054,792 | -4.46% |
| 30 Sep, 21 | 14,710,733 | 1.36% |
| 30 Jun, 21 | 14,513,290 | - |
Vera Therapeutics (VERA) has 6.72M shares outstanding as of 30 Jun 24, down -86.91% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 13.18% | 0.13% |
| 31 Mar, 24 | 100.66% | 1.07% |
| 31 Dec, 23 | 96.81% | 1.24% |
| 30 Sep, 23 | 88.49% | 1.19% |
| 30 Jun, 23 | 86.13% | 0.88% |
| 31 Mar, 23 | 99.17% | 1.68% |
| 31 Dec, 22 | 76.73% | 1.22% |
| 30 Sep, 22 | 79.14% | 1.40% |
| 30 Jun, 22 | 75.32% | 1.14% |
| 31 Mar, 22 | 81.21% | 1.86% |
| 31 Dec, 21 | 66.05% | 1.38% |
| 30 Sep, 21 | 69.18% | 1.38% |
| 30 Jun, 21 | 70.87% | - |
As of 30 Jun 24, Vera Therapeutics is held by 13.18% institutional shareholders, representing a 0.13% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 28 | -77.60% |
| 31 Mar, 24 | 125 | 131.48% |
| 31 Dec, 23 | 54 | - |
| 30 Sep, 23 | 54 | 3.85% |
| 30 Jun, 23 | 52 | 1.96% |
| 31 Mar, 23 | 51 | 59.38% |
| 31 Dec, 22 | 32 | - |
| 30 Sep, 22 | 32 | 28.00% |
| 30 Jun, 22 | 25 | -34.21% |
| 31 Mar, 22 | 38 | 40.74% |
| 31 Dec, 21 | 27 | 17.39% |
| 30 Sep, 21 | 23 | 9.52% |
| 30 Jun, 21 | 21 | - |
28 institutional shareholders have increased their position in VERA stock as of 30 Jun 24 compared to 125 in the previous quarter (a -77.60% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 13 | -56.67% |
| 31 Mar, 24 | 30 | 42.86% |
| 31 Dec, 23 | 21 | 31.25% |
| 30 Sep, 23 | 16 | -20.00% |
| 30 Jun, 23 | 20 | 122.22% |
| 31 Mar, 23 | 9 | -30.77% |
| 31 Dec, 22 | 13 | 44.44% |
| 30 Sep, 22 | 9 | -18.18% |
| 30 Jun, 22 | 11 | 37.50% |
| 31 Mar, 22 | 8 | 60.00% |
| 31 Dec, 21 | 5 | 66.67% |
| 30 Sep, 21 | 3 | - |
| 30 Jun, 21 | - | - |
13 institutional shareholders have reduced their position in VERA stock as of 30 Jun 24 compared to 30 in the previous quarter (a -56.67% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 48 | -71.76% | 6,715,916 | -86.91% | 13.18% | 0.13% | 28 | -77.60% | 13 | -56.67% |
| 31 Mar, 24 | 170 | 75.26% | 51,310,371 | 24.10% | 100.66% | 1.07% | 125 | 131.48% | 30 | 42.86% |
| 31 Dec, 23 | 97 | 12.79% | 41,345,655 | 5.32% | 96.81% | 1.24% | 54 | - | 21 | 31.25% |
| 30 Sep, 23 | 86 | 2.38% | 39,258,889 | 2.97% | 88.49% | 1.19% | 54 | 3.85% | 16 | -20.00% |
| 30 Jun, 23 | 84 | 15.07% | 38,127,621 | 2.07% | 86.13% | 0.88% | 52 | 1.96% | 20 | 122.22% |
| 31 Mar, 23 | 73 | 25.86% | 37,354,444 | 75.10% | 99.17% | 1.68% | 51 | 59.38% | 9 | -30.77% |
| 31 Dec, 22 | 58 | 5.45% | 21,332,619 | -0.96% | 76.73% | 1.22% | 32 | - | 13 | 44.44% |
| 30 Sep, 22 | 55 | 10.00% | 21,539,850 | 5.61% | 79.14% | 1.40% | 32 | 28.00% | 9 | -18.18% |
| 30 Jun, 22 | 50 | - | 20,394,973 | 3.66% | 75.32% | 1.14% | 25 | -34.21% | 11 | 37.50% |
| 31 Mar, 22 | 50 | 35.14% | 19,674,561 | 39.98% | 81.21% | 1.86% | 38 | 40.74% | 8 | 60.00% |
| 31 Dec, 21 | 37 | 19.35% | 14,054,792 | -4.46% | 66.05% | 1.38% | 27 | 17.39% | 5 | 66.67% |
| 30 Sep, 21 | 31 | 47.62% | 14,710,733 | 1.36% | 69.18% | 1.38% | 23 | 9.52% | 3 | - |
| 30 Jun, 21 | 21 | - | 14,513,290 | - | 70.87% | - | 21 | - | - | - |
Vera Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Vera Therapeutics's stock was made by Fordyce Marshall on Aug 16 2024, selling 15,625 shares at $2.90 per share (valued at $45.26K).
Vera Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | 2 | 100.00% |
| Q2 2024 | 12 | 28 | 42.86% |
| Q1 2024 | 9 | 9 | 100.00% |
| Q4 2023 | 2 | 3 | 66.67% |
| Q3 2023 | 2 | 5 | 40.00% |
| Q2 2023 | 9 | - | - |
| Q1 2023 | 30 | 1 | 3000.00% |
| Q4 2022 | 18 | 21 | 85.71% |
| Q3 2022 | 8 | 22 | 36.36% |
| Q2 2022 | 14 | 6 | 233.33% |
| Q1 2022 | 10 | - | - |
| Q4 2021 | 1 | 1 | 100.00% |
| Q3 2021 | 1 | 1 | 100.00% |
| Q2 2021 | 28 | 24 | 116.67% |
| Q3 2013 | - | 7 | - |
| Q2 2013 | 1 | 1 | 100.00% |
| Q1 2013 | 1 | 1 | 100.00% |
| Q4 2012 | - | 1 | - |
| Q2 2012 | 2 | - | - |
| Q2 2011 | 1 | - | - |
2 total buy trades, and 2 total sell trades (buy/sell ratio of 1.00%) were made by Vera Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | 24 | - |
| Q1 2024 | 1 | 7 | 14.29% |
| Q4 2023 | - | - | - |
| Q3 2023 | - | 3 | - |
| Q2 2023 | 2 | - | - |
| Q1 2023 | 24 | - | - |
| Q4 2022 | - | 8 | - |
| Q3 2022 | - | 14 | - |
| Q2 2022 | 4 | 3 | 133.33% |
| Q1 2022 | 5 | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | 7 | - | - |
| Q3 2013 | - | - | - |
| Q2 2013 | - | - | - |
| Q1 2013 | - | - | - |
| Q4 2012 | - | - | - |
| Q2 2012 | - | - | - |
| Q2 2011 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Vera Therapeutics's stocks.
Vera Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| ANAB | AnaptysBio, Inc. |
| DICE | DICE Therapeutics, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| ALDX | Aldeyra Therapeutics, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| VTYX | Ventyx Biosciences, Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| TVTX | Travere Therapeutics, Inc. |
| COGT | Cogent Biosciences, Inc. |
| LIAN | LianBio |
| ETON | Eton Pharmaceuticals, Inc. |
| TYRA | Tyra Biosciences, Inc. |
| RLYB | Rallybio Corporation |
| CNTB | Connect Biopharma Holdings Limited |
| GLUE | Monte Rosa Therapeutics, Inc. |
| TARS | Tarsus Pharmaceuticals, Inc. |
| THRD | Third Harmonic Bio, Inc. |
| XLO | Xilio Therapeutics, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| ADAG | Adagene Inc. |
| CYTK | Cytokinetics, Incorporated |
| RAPT | RAPT Therapeutics, Inc. |
VERA Ownership FAQ
Who Owns Vera Therapeutics?
Vera Therapeutics is owned by institutional shareholders (13.18%), insiders (7.85%), and public (78.98%). The largest institutional shareholder of Vera Therapeutics is AVORO CAPITAL ADVISORS LLC (8.45% of total shares) and the top mutual fund owner is T. Rowe Price New Horizons Fund, Inc. (0.21% of total shares).
Who are the major institutional shareholders of Vera Therapeutics?
Vera Therapeutics's major institutional shareholders are AVORO CAPITAL ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, BLACKROCK INC., FMR LLC, and SOFINNOVA INVESTMENTS, INC.. The top five shareholders own together 33.08% of the company's share outstanding.
How many Vera Therapeutics shareholders are there?
As of Jun 2024, there are 48 institutional shareholders of Vera Therapeutics.
What percentage of Vera Therapeutics is owned by AVORO CAPITAL ADVISORS LLC?
AVORO CAPITAL ADVISORS LLC owns 4.31M shares of Vera Therapeutics, representing 8.45% of the company's total shares outstanding, valued at $155.92M (as of Jun 2024).
What percentage of Vera Therapeutics is owned by PRICE T ROWE ASSOCIATES INC /MD/?
As of Jun 2024, PRICE T ROWE ASSOCIATES INC /MD/ holds 3.62M shares of Vera Therapeutics (VERA), compromising 7.10% of the company, valued at $130.98M.
What percentage of Vera Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Vera Therapeutics. The company owns 3.34M of the company's shares outstanding (worth $120.76M).